Jiangsu Jibeier Pharmaceutical's decent performance is refle...
Jiangsu Jibeier Pharmaceutical's decent performance is reflected in its ROE and net income growth, attributed to reinvesting high-return profits. Analysts predict continued growth in earnings.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more